Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an end. Catalysts in the drug production ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
Image source: Getty Images. Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield-- the highest among major drug ...
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).
Pfizer's dividends should keep flowing and growing.